New study examines the therapeutic benefits of using marijuana to treat epilepsy which cannot be controlled with usual anticonvulsants.

‘Clinical trials are essential to study the potential cannabidiol compound in marijuana to use it as an antiepileptic drug since no concrete evidence is available.’

There is no evidence to guide physicians in ranking cannabidiol among current antiepileptic drugs, and it will be important to continue studying its potential through rigorous clinical trials.




"The emergence over the past 12 months of the first successful double-blind, randomized controlled trials of cannabidiol is good news for some desperate families of children with severe epilepsy.
These studies are a reminder though that this drug is no miracle, and we still have much to learn," said co-author Dr. John Anthony Lawson, of Sydney Children's Hospital, Randwick, in Australia.
Source-Eurekalert